Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: A preliminary report

Journal of Crohn's and Colitis

Volumn 8, Issue 11, 2014, Pages 1464-1470

  Turner, Dan ^a   Levine, Arie ^b   Kolho, Kaija Leena ^c   Shaoul, Ron ^d   Ledder, Oren ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Antibiotics; Children; Doxycyline; Severe UC; Ulcerative colitis; Vancomycin

Indexed keywords

ADALIMUMAB; ALBUMIN; AMOXICILLIN; C REACTIVE PROTEIN; CIPROFLOXACIN; DOXYCYCLINE; GANCICLOVIR; GENTAMICIN; HEMOGLOBIN; INFLIXIMAB; MERCAPTOPURINE; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALBUMIN BLOOD LEVEL; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BACTERIUM CULTURE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SIGMOIDOSCOPY; STEROID THERAPY; TOTAL PARENTERAL NUTRITION; TREATMENT RESPONSE; ULCERATIVE COLITIS; ADOLESCENT; ANTAGONISTS AND INHIBITORS; BLOOD; CLINICAL TRIAL; COLITIS, ULCERATIVE; DRUG COMBINATION; DRUG RESISTANCE; METABOLISM; MULTICENTER STUDY; RETREATMENT; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CHILD; COLITIS, ULCERATIVE; DOXYCYCLINE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METRONIDAZOLE; REMISSION INDUCTION; RETREATMENT; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; VANCOMYCIN;

EID: 84927797177     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.05.010     Document Type: Article

References (29)

1. Bakhtiar S.M., LeBlanc J.G., Salvucci E., Ali A., Martin R., Langella P., et al. Implications of the human microbiome in inflammatory bowel diseases. FEMS Microbiol Lett May 2013, 342(1):10-17. [PubMed PMID: 23431991].
2. Michail S., Durbin M., Turner D., Griffiths A.M., Mack D.R., Hyams J., et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis Oct 2012, 18(10):1799-1808. [PubMed PMID: 22170749. Pubmed Central PMCID: 3319508].
3. Wang S.L., Wang Z.R., Yang C.Q. Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease. Exp Ther Med Dec 2012, 4(6):1051-1056. [PubMed PMID: 23226773, Pubmed Central PMCID: 3494118].
4. Ohkusa T., Kato K., Terao S., Chiba T., Mabe K., Murakami K., et al. Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial. Am J Gastroenterol 2010, 105(8):1820-1829.
5. Ohkusa T., Nomura T., Terai T., Miwa H., Kobayashi O., Hojo M., et al. Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up. Scand J Gastroenterol 2005, 40(11):1334-1342.
6. Terao S., Yamashiro K., Tamura I., Hirano T., Ohkusa T., Kato K. Antibiotic combination therapy for steroid withdrawal in steroid-dependent ulcerative colitis. Digestion 2011, 83(3):198-203. [PubMed PMID: 21266816].
7. Ohkusa T., Okayasu I., Ogihara T., Morita K., Ogawa M., Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut Jan 2003, 52(1):79-83. [PubMed PMID: 12477765, Pubmed Central PMCID: 1773498].
8. Dickinson R.J., O'Connor H.J., Pinder I., Hamilton I., Johnston D., Axon A.T. Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 1985, 26(12):1380-1384.
9. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr Jul 2005, 41(1):1-7. [PubMed PMID: 15990620].
10. Turner D., Otley A.R., Mack D., Hyams J., de Bruijne J., Uusoue K., et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007, 133(2):423-432. [PubMed PMID: 17681163].
11. Turner D., Hyams J., Markowitz J., Lerer T., Mack D.R., Evans J., et al. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis Aug 2009, 15(8):1218-1223. [PubMed PMID: 19161178, Epub 2009/01/24. Eng].
12. Turner D., Walsh C.M., Benchimol E.I., Mann E.H., Thomas K.E., Chow C., et al. Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for second-line therapy. Gut Mar 2008, 57(3):331-338. [PubMed PMID: 17981888, Epub 2007/11/06. eng].
13. Turner D., Mack D., Leleiko N., Walters T.D., Uusoue K., Leach S.T., et al. Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology Jun 2010, 138(7):2282-2291. [PubMed PMID: 20193683, Epub 2010/03/03. Eng].
14. Inokuchi T., Kato J., Hiraoka S., Suzuki H., Nakarai A., Hirakawa T., et al. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status. World J Gastroenterol Jan 14 2014, 20(2):509-517. [PubMed PMID: 24574719].
15. Chen W., Chadwick V., Tie A., Harp J. Cryptosporidium parvum in intestinal mucosal biopsies from patients with inflammatory bowel disease. Am J Gastroenterol Dec 2001, 96(12):3463-3464. [PubMed PMID: 11774987].
16. Berg A.M., Kelly C.P., Farraye F.A. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis Jan 2013, 19(1):194-204. [PubMed PMID: 22508484].
17. Zitomersky N.L., Atkinson B.J., Franklin S.W., Mitchell P.D., Snapper S.B., Comstock L.E., et al. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS ONE 2013, 8(6):e63686. [PubMed PMID: 23776434, Pubmed Central PMCID: 3679120].
18. Chapman R.W., Selby W.S., Jewell D.P. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut Oct 1986, 27(10):1210-1212. [PubMed PMID: 3536677, Epub 1986/10/01. eng].
19. Mantzaris G.J., Petraki K., Archavlis E., Amberiadis P., Kourtessas D., Christidou A., et al. A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. Scand J Gastroenterol Sep 2001, 36(9):971-974. [PubMed PMID: 11521989].
20. Mantzaris G.J., Hatzis A., Kontogiannis P., Triadaphyllou G. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol Jan 1994, 89(1):43-46. [PubMed PMID: 8273796].
21. Burke D.A., Axon A.T., Clayden S.A., Dixon M.F., Johnston D., Lacey R.W. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990, 4(2):123-129.
22. Turunen U.M., Farkkila M.A., Hakala K., Seppala K., Sivonen A., Ogren M., et al. Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study. Gastroenterology 1998, 115(5):1072-1078.
23. Gionchetti P., Rizzello F., Ferrieri A., Venturi A., Brignola C., Ferretti M., et al. Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. Dig Dis Sci Jun 1999, 44(6):1220-1221. [PubMed PMID: 10389700, Epub 1999/07/02. eng].
24. Mantzaris G.J., Archavlis E., Christoforidis P., Kourtessas D., Amberiadis P., Florakis N., et al. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol Mar 1997, 92(3):454-456. [PubMed PMID: 9068468, Epub 1997/03/01. eng].
25. Turner D., Griffiths A.M., Veerman G., Johanns J., Damaraju L., Blank M., et al. Endoscopic and clinical variables that predict sustained remission in children with ulcerative colitis treated with infliximab. Clin Gastroenterol Hepatol Nov 2013, 11(11):1460-1465. [PubMed PMID: 23672831].
26. Turner D., Seow C.H., Greenberg G.R., Griffiths A.M., Silverberg M.S., Steinhart A.H. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol Oct 2009, 7(10):1081-1088. [PubMed PMID: 19577010, Epub 2009/07/07. eng].
27. Lobo A.J., Burke D.A., Sobala G.M., Axon A.T. Oral tobramycin in ulcerative colitis: effect on maintenance of remission. Aliment Pharmacol Ther Apr 1993, 7(2):155-158. [PubMed PMID: 8485268, Epub 1993/04/01. eng].
28. Turner D., Levine A., Escher J.C., Griffiths A.M., Russell R.K., Dignass A., et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr Sep 2012, 55(3):340-361. [PubMed PMID: 22773060].
29. Turner D., Travis S.P., Griffiths A.M., Ruemmele F.M., Levine A., Benchimol E.I., et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol Apr 2011, 106(4):574-588. [PubMed PMID: 21224839. eng.].